These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10709996)

  • 1. Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope.
    Atley LM; Mort JS; Lalumiere M; Eyre DR
    Bone; 2000 Mar; 26(3):241-7. PubMed ID: 10709996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K.
    Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J
    Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
    Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
    J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The collagenolytic activity of cathepsin K is unique among mammalian proteinases.
    Garnero P; Borel O; Byrjalsen I; Ferreras M; Drake FH; McQueney MS; Foged NT; Delmas PD; Delaissé JM
    J Biol Chem; 1998 Nov; 273(48):32347-52. PubMed ID: 9822715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone.
    Apone S; Lee MY; Eyre DR
    Bone; 1997 Aug; 21(2):129-36. PubMed ID: 9267687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate.
    Li Z; Hou WS; Escalante-Torres CR; Gelb BD; Bromme D
    J Biol Chem; 2002 Aug; 277(32):28669-76. PubMed ID: 12039963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys.
    Kumar S; Dare L; Vasko-Moser JA; James IE; Blake SM; Rickard DJ; Hwang SM; Tomaszek T; Yamashita DS; Marquis RW; Oh H; Jeong JU; Veber DF; Gowen M; Lark MW; Stroup G
    Bone; 2007 Jan; 40(1):122-31. PubMed ID: 16962401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.
    Stroup GB; Lark MW; Veber DF; Bhattacharyya A; Blake S; Dare LC; Erhard KF; Hoffman SJ; James IE; Marquis RW; Ru Y; Vasko-Moser JA; Smith BR; Tomaszek T; Gowen M
    J Bone Miner Res; 2001 Oct; 16(10):1739-46. PubMed ID: 11585335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational studies on the specific cleavage site of Type I collagen (alpha-1) fragment (157-192) by cathepsins K and L by proton NMR spectroscopy.
    Nosaka AY; Kanaori K; Teno N; Togame H; Inaoka T; Takai M; Kokubo T
    Bioorg Med Chem; 1999 Feb; 7(2):375-9. PubMed ID: 10218831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts.
    Ljusberg J; Wang Y; Lång P; Norgård M; Dodds R; Hultenby K; Ek-Rylander B; Andersson G
    J Biol Chem; 2005 Aug; 280(31):28370-81. PubMed ID: 15929988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix.
    Kafienah W; Brömme D; Buttle DJ; Croucher LJ; Hollander AP
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):727-32. PubMed ID: 9560298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone.
    Hanson DA; Eyre DR
    J Biol Chem; 1996 Oct; 271(43):26508-16. PubMed ID: 8900119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Bone Resorption during Lactation in Pycnodysostosis.
    Jansen IDC; Papapoulos SE; Bravenboer N; de Vries TJ; Appelman-Dijkstra NM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
    Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
    J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme.
    Brömme D; Okamoto K; Wang BB; Biroc S
    J Biol Chem; 1996 Jan; 271(4):2126-32. PubMed ID: 8567669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differently cross-linked and uncross-linked carboxy-terminal telopeptides of type I collagen in human mineralised bone.
    Eriksen HA; Sharp CA; Robins SP; Sassi ML; Risteli L; Risteli J
    Bone; 2004 Apr; 34(4):720-7. PubMed ID: 15050904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage.
    Dejica VM; Mort JS; Laverty S; Percival MD; Antoniou J; Zukor DJ; Poole AR
    Am J Pathol; 2008 Jul; 173(1):161-9. PubMed ID: 18511517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel class of nonpeptidic biaryl inhibitors of human cathepsin K.
    Robichaud J; Oballa R; Prasit P; Falgueyret JP; Percival MD; Wesolowski G; Rodan SB; Kimmel D; Johnson C; Bryant C; Venkatraman S; Setti E; Mendonca R; Palmer JT
    J Med Chem; 2003 Aug; 46(17):3709-27. PubMed ID: 12904076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsins in the osteoclast.
    Goto T; Yamaza T; Tanaka T
    J Electron Microsc (Tokyo); 2003; 52(6):551-8. PubMed ID: 14756243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
    J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.